PVF2, a PDGF/VEGF-like growth factor, induces hemocyte proliferation in Drosophila larvae

EMBO Reports

Volumn 3, Issue 12, 2002, Pages 1195-1200

  Munier, Ann Isabelle ^b   Doucet, Daniel ^b   Perrodou, Emmanuel ^b   Zachary, Daniel ^b   Meister, Marie ^b   Hoffmann, Jules A ^b   Janeway Jr , Charles A ^a   Lagueux, Marie ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UPR 9022 CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; LIGAND; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN PVF2; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN DETECTION; BLOOD CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; HEMATOPOIESIS; IN VITRO STUDY; IN VIVO STUDY; LARVA; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SEQUENCE HOMOLOGY; STEM CELL;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELL DIFFERENTIATION; DROSOPHILA; HEMOCYTES; IMMUNOHISTOCHEMISTRY; LARVA; LIGANDS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALIA; ARACHNIDA; HEXAPODA; MAMMALIA;

EID: 4644293902     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1093/embo-reports/kvf242     Document Type: Review

References (27)

1. Brown, S., Hu, N. and Hombria J.C. (2001) Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless. Curr. Biol., 11, 1700-1705.
2. Cho, N.K., Keyes, L., Johnson, E., Heller, J., Ryner, L., Karim, F. and Krasnow, M.A. (2002) Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell, 108, 865-876.
3. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W. (1999) Current Protocols in Immunology. John Wiley & Sons, New York.
4. Dimarcq, J.L., Imler, J.L., Lanot, R., Ezekowitz, R.A., Hoffmann, J.A., Janeway, C.A. and Lagueux, M. (1997) Treatment of 1(2)mbn Drosophila tumorous blood cells with the steroid hormone ecdysone amplifies the inducibility of antimicrobial peptide gene expression. Insect Biochem. Mol. Biol., 27, 877-886.
5. Duchek, P., Somogyi, K., Jekely, G., Beccari, S. and Rorth, P. (2001) Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell, 107, 17-26.
6. Franc, N.C., Dimarcq, J.L., Lagueux, M., Hoffmann, J. and Ezekowitz, R.A. (1996) Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity, 4, 431-443.
7. Gateff, E., Gissmann, L., Shresta, R., Plus, N., Pfister, H., Schröder, J. and Zur Hausen, H. (1980) Characterization of two tumorous blood cell lines of Drosophila melanogaster and the viruses they contain. In Kurstat, E., Maramorosch, F. and Dübendorfer, A. (eds), Invertebrate Systems in vitro. Elsevier/North Holland Biomedical Press, Amsterdam, pp. 517-533.
8. Giebel, B. and Campos-Ortega, J.A. (1997) Functional dissection of the Drosophila enhancer of split protein, a suppressor of neurogenesis. Proc. Natl Acad. Sci. USA, 94, 6250-6254.
9. Hanratty, W.P. and Dearolf, C.R. (1993) The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol. Gen. Genet., 238, 33-37.
10. Hanratty, W.P. and Ryerse, J.S. (1981) A genetic melanotic neoplasm of Drosophila melanogaster. Dev. Biol., 83, 238-249.
11. Harrison, D.A., Binari, R., Nahreini, T.S., Gilman, M. and Perrimon, N. (1995) Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J., 14, 2857-2865.
12. Harrison, D.A., McCoon, P.E., Binari, R., Gilman, M. and Perrimon, N. (1998) Drosophila impaired encodes a secreted protein that activates the JAK signaling pathway. Genes Dev., 12, 3252-3263.
13. Heino, T.I., Karpanen, T., Wahlstrom, G., Pulkkinen, M., Eriksson, U., Alitalo, K. and Roos, C. (2001) The Drosophila VEGF receptor homolog is expressed in hemocytes. Mech. Dev., 109, 69-77.
14. Hoffmann, J.A. and Reichhart, J.M. (2002) Drosophila innate immunity: an evolutionary perspective. Nat. Immunol., 3, 121-126.
15. Lanot, R., Zachary, D., Holder, F. and Meister, M. (2001) Postembryonic hematopoiesis in Drosophila. Dev. Biol., 230, 243-257.
16. Lebestky, T., Chang, T., Hartenstein, V. and Banerjee, U. (2000) Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science, 288, 146-149.
17. Luo, H., Hanratty, W.P. and Dearolf, C.R. (1995) An amino acid substitution in the Drosophila hopTum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J., 14, 1412-1420.
18. Luo, H., Rose, P.E., Roberts, T.M. and Dearolf, C.R. (2002) The Hopscotch Jak kinase requires the Raf pathway to promote blood cell activation and differentiation in Drosophila. Mol. Genet. Genom., 267, 57-63.
19. Mozdzanowski, J., Hembach, P. and Speicher, D.W. (1992) High yield electroblotting onto polyvinylidene difluoride membranes from polyacrylamide gels. Electrophoresis, 13, 59-64.
20. Porter, A.C. and Vaillancourt, R.R. (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene, 17, 1343-1352.
21. Ramet, M., Manfruelli, P., Pearson, A., Mathey-Prevot, B. and Ezekowitz, R.A. (2002) Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature, 416, 644-648.
22. Remillieux-Leschelle, N., Santamaria, P. and Randsholt N.B. (2002) Regulation of larval hematopoiesis in Drosophila melanogaster-a role for the multi sex combs gene. Genetics, in press.
23. Rizki, T.M., Rizki, R.M. and Grell, E.H. (1980) A mutant affecting the crystal cells in Drosophila melanogaster. Experientia, 36, 1223-1226.
24. Scheijen, B. and Griffin, J.D. (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene, 21, 3314-3333.
25. Tepass, U., Fessler, L.I., Aziz, A. and Hartenstein, V. (1994) Embryonic origin of hemocytes and their relationship to cell death in Drosophila. Development, 120, 1829-1837.
26. Vignais, M.L. and Gilman, M. (1999) Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system. Mol. Cell. Biol., 19, 3727-3735.
27. Zhao, S. et al. (2002) JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells. EMBO J., 21, 2159-2167.